Tobacco Investment Means E-Cigarette Growth, But Drug Path Raises Questions

Stakeholders discussed electronic cigarettes at an FDA public hearing on smoking cessation, reflecting big tobacco’s buy-in to the market. Firms appear to have a choice between remaining in tobacco’s regulatory space, or following the costly, potentially unclear route to an NDA.